Money & Corp · District Court, District of Columbia
1d
AI illustrationGenentech wants enforced against Novartis. Can the court do it?
Your callShould the court enforce the arbitration decision against Novartis?
TL;DR
- 1Genentech says it won a binding arbitration decision on April 14, 2025, against Novartis about product licenses.
- 2They claim that Novartis is incorrectly saying Genentech violated their licensing agreements concerning the product Vabysmo®.
- 3Genentech is now asking the court to enforce the arbitration decision, which includes Novartis paying over $17 million in costs and confirming their interpretation of the licensing terms.
Vote to earn 10 Verdict Points




